Press Releases
Phunware Reports Third Quarter 2026 Financial Results
Advances Phunware 2.0 Rollout, with Four Major Hospitality Groups in Discussions Gross Profit Increases 61.2%; Gross Margin Expands to 56.7% from 38.1% Ends Quarter with $86.7 Million in Cash and No Debt AUSTIN, Texas, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Phunware, Inc. (“Phunware” or the “Company”) (NASDAQ: PHUN), a provider of AI-enabled guest intelligence software to operators of hotels, resorts, and other large, complex properties, today reported financial results for the third quarter ended September 30, 2026. Management Commentary “We made meaningful progress on Phunware 2.0 during the third quarter, both in how we develop products and how we reach customers,” said Dmitry Kroshka, Chief Executive Officer of Phunware...
MetaVia Presents Preclinical Data Supporting the Potential of DA-1726 to Address Liver Disease and Weight Loss at ObesityWeek® 2026
Statistically Significant Increase in Liver and Circulating FGF21 Expression Greater Glucose Lowering and Comparable Weight Loss vs. Retatrutide with Less Reliance on Appetite Suppression MetaVia Preparing to Initiate a Phase 2 Study in MetALD and ALD in the Second Half of 2027 CAMBRIDGE, Mass.
JE Cleantech Holdings Limited Announces Declaration of Cash Dividend
SINGAPORE, Nov. 16, 2026 (GLOBE NEWSWIRE) -- JE Cleantech Holdings Limited (Nasdaq: JCSE), a precision cleaning and cleantech equipment manufacturer, today announced that its Board of Directors approved a cash dividend of US$0.20 per ordinary share, to be funded out of the Company's share premium account. The dividend is payable to shareholders of record at the close of business on November 30, 2026 (New York Time). The payment date is expected to be on or around December 11, 2026...
WTW's Kristy Banas Recognized with the 2026 N2Growth Leaders40 Top CHRO Award
NEW YORK, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Kristy Banas, CHRO at WTW, has been named one of 40 executives worldwide recognized with the 2026 N2Growth Leaders40 Top Chief Human Resources Officer Award. The annual award is the benchmark for excellence in human resources, celebrating the leaders shaping careers, cultures and talent at the world's most people-driven companies...
Prenetics' IM8 Announces Three-Time GRAMMY-Winning DJ and Producer Diplo as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
— Diplo is IM8's first Global Ambassador from music and takes a roster built in elite sport onto the world's biggest stages — Diplo brings a social following of more than 12 million across Instagram, TikTok and YouTube, and more than 40 million monthly listeners on Spotify — IM8 becomes Diplo's exclusive partner in the all-in-one nutrition and longevity categories and joins Diplo's Run Club, named one of Fast Company's Most Innovative Companies of 2026, across its North American season — Joins an equity-aligned roster of David Beckham, Giannis Antetokounmpo, Aryna Sabalenka, Ollie Bearman, Jay Shetty, Lily Collins and Inter Miami CF NEW YORK, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health company and parent of the AI-native direct-to-consumer wellness brand IM8, co-founded by Sir David Beckham, today announced a multi-year global partnership with three-time GRAMMY Award-winning artist, DJ and producer Diplo, founder of Diplo's Run Club. Diplo becomes a Global Ambassador of IM8 and a shareholder in Prenetics, demonstrating his long-term conviction in the brand and the Company, and IM8 will serve as his exclusive partner in the all-in-one nutrition and longevity categories...
MindBio Achieves Significant Product Development Milestone with up to 83% Accuracy in Intoxication Detection Using Voice Analytics and AI; Announces Private Placement
MindBio Achieves Significant Product Development Milestone. This is the product development inflection point management has been patiently working towards
Zenta Group Signs Binding MOU for Strategic Acquisition of Controlling Stake in SE Asia-Based AI Technology Start-Up
MACAU, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Zenta Group Company Limited (“Zenta Group” or the “Company”) (Nasdaq: ZTG), a Macau-based professional services provider which has recently re-aligned its business focus toward AI and data solutions, today announces that it has executed a binding Memorandum of Understanding (the “MOU”) to acquire a controlling stake in a privately held AI technology start-up based in SE Asia (the “Target”). The Target is setting up two core businesses, with its market layout focused on Southeast Asia and South America...
Draganfly Signs Exclusive Agreement to Provide Drone Manufacturing in the Philippines
Canadian drone technology and engineering expertise to build, expand and support Philippine capabilities in drones and autonomous systems across public safety, infrastructure and critical industrial sectors.
Microbot Medical® Files 10-Q and Highlights Key Third Quarter Operating Achievements
Company continues to expand commercial presence in the U.S. while it progresses international market entry and opportunities Increased the number of health systems and hospital sites using LIBERTY, while utilization of the LIBERTY System rose 44% compared to the second quarter HINGHAM, Mass., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY Endovascular Robotic System, today announced that it has filed its Quarterly Report on Form 10-Q for the third quarter ended September 30, 2026, with the Securities and Exchange Commission...
Global Mofy Announces Indirect Investment in Anthropic, Strengthening Its Position in the Global AI Ecosystem
BEIJING, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (Nasdaq: GMM) (the “Company” or “Global Mofy”), a generative AI-driven technology solutions provider focused on virtual content production and digital assets, today announced that it indirectly invested in Anthropic in September 2026, marking another step in the Company's strategic positioning in the artificial intelligence (“AI”) sector. Global Mofy participates indirectly in an investment related to Anthropic through a subscription to an investment fund...
Eva Live Outlines AI Software Expansion and Eva Defense Development Milestones Following Third Quarter 2026 Results
Company highlights two operating software platforms, three additional offerings targeted for fourth-quarter launch, civilian drone beta testing, and measurable Eva X Mini development objectives, alongside $1.81 million in reported third-quarter AI-driven marketing services revenue.
GoldHaven Completes Inaugural Drill Program at Magno Project, Intersecting Multiple Mineralized Zones
Drilling encounters broad tungsten-bearing skarn intervals at Kuhn and multiple zones of semi-massive to massive sulphides at D Zone; assay results pending Drilling encounters broad tungsten-bearing skarn intervals at Kuhn and multiple zones of semi-massive to massive sulphides at D Zone; assay results pending
Click Holdings (NASDAQ: CLIK) Reports Strong Q1 FY2026/27 Results; Revenue Up Over 45%; All Segments Grow, Nursing Margins Improve, Operating Net Income Expected to Hit New High
Hong Kong, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Click Holdings Limited (“Click Holdings” or “Click” or “we” or “us”, NASDAQ: CLIK) and its subsidiaries (collectively, the “Company”), a leader in human resources (“HR”) and senior care solutions in Hong Kong, today provided an operating data update for the first quarter (“Q1”) of the 2026/27 financial year (July to September 2026). Key Operating Highlights for Q1 FY2026/27 Total revenue increased by over 45% compared with Q1 of FY2025/26...
Trust Stamp provided a report for the nine months ending September 30, 2026 including a 37% increase in net revenue for Q3 and a 28% increase in net revenue for the nine-month period when compared to the comparable periods in 2025, with the growth in revenue significantly outpacing the growth in cash expenses
ATLANTA, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI) announced that: Net recognised revenue for the nine months ended September 30, 2026 was $2.85 million, an increase of 28% from $2.23 million for the corresponding period in 2025 and 37% for Q3, primarily attributable to increased revenue from the Company's S&P 500 bank customer and $629 thousand recognized revenue during the nine months ended 30 September 2026 for work with a multinational telecommunications corporation, with an additional $294 thousand of work completed for that customer during the nine month period but not billed and recognized as at September 30, 2026. Additional contracted work and usage based revenue continues for that customer and will be billed and recognized in future quarters...
Cycurion Reports Record Quarterly Revenue and Gross Profit as Revenue Grows 40% and Gross Margin Reaches 36%
Revenue exceeds Wall Street consensus estimate of $4.37 million Gross Profit More Than Seven Times Prior Year • Operating Loss Narrows 35% • Adjusted EBITDA Loss Narrows 64% MCLEAN, Va., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) ("Cycurion" or the "Company"), a predictive cybersecurity company delivering AI-driven cybersecurity, national security, and public safety technology solutions, today announced its financial results for the third quarter ended September 30, 2026...
Nasdaq and Mercedes-AMG PETRONAS F1 Team Renew Multi-Year Partnership
NEW YORK, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) and the Mercedes-AMG PETRONAS F1 Team today announced a multi-year extension of their partnership, building on two successful seasons of collaboration. The next phase will deepen a relationship grounded in a shared commitment to innovation, high performance and investing in the people and ideas that drive long-term success...
Namib Minerals Reports Strong Initial Operating Leverage From Expanded How Mine Mill
NEW YORK, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Namib Minerals (Nasdaq: NAMM) (“Namib” or the “Company”), an established African gold producer with a portfolio of mining assets in Zimbabwe, today provided an update on the performance of the recently commissioned expanded milling plant (the “Expanded Mill”) at How Mine...
Osisko Gold Announces Grant of Incentive Awards
TORONTO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Osisko Gold Group Inc. (NYSE: OGG, TSXV: OGG) ("Osisko Gold" or the "Company") announces that it has granted an aggregate of (i) 128,350 stock options of the Company (the "Options"), and (ii) 96,264 restricted share units of the Company ("RSUs") to certain newly hired non-executive employees and a senior officer (collectively, the "Incentive Awards"), pursuant to the Company's omnibus equity incentive plan ("Omnibus Plan")...
SuperCom Chairman Purchases 19,600 Ordinary Shares and Plans to Purchase Up to 150,000 Shares in Total
TEL AVIV, Israel, Nov. 16, 2026 /PRNewswire/ -- SuperCom Ltd. (NASDAQ: SPCB), a global provider of secured solutions for the IoT, cybersecurity and digital identity sectors, today announced that Mr.
Scott+Scott Attorneys at Law LLP Launches Investigation Into Arbor Realty Trust, Inc. (ABR)
New York, New York--(Newsfile Corp. - November 16, 2026) - Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a shareholder and consumer rights litigation firm, alerts investors that it is investigating potential violations of U.S. federal securities laws involving Arbor Realty Trust, Inc. (NYSE: ABR). CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION What is Arbor Realty?
Oasis Management Publishes Presentation Highlighting the Need for Shareholder-Led Change at Vail Resorts
Describes Operational Mismanagement, Persistent Underperformance and the Board's Failure to Fulfill Its Core Responsibilities Details Initiatives for "Lifting the Vail" Believes Electing Robert Chapek and M. Ashton Hudson to the Board Would Add Needed Expertise, Urgency and Accountability AUSTIN, Texas, Nov. 16, 2026 /PRNewswire/ -- Oasis Management Company Ltd...
Forge Nano Reports Third Quarter 2026 Results; Raises Over $130 Million; Reiterates Guidance
DENVER, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Forge Nano Holdings, Inc. (NASDAQ: NANO) (“Forge Nano” or the “Company”), a U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition (“ALD”) technology for next-generation semiconductor and battery applications, today announced its financial and operating results for the third quarter ended September 30, 2026, and highlighted recent commercial and strategic milestones...
HeartCore Reports Third Quarter 2026 Financial Results
NEW YORK and TOKYO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, reported financial results for the third quarter and nine months ended September 30, 2026.
Vertiv ATLAS Proves AI Infrastructure Ahead of Silicon
System-level testing and validation addresses density, speed, scale, complexity and dynamic load profiles before next-generation compute reaches the market Engineering collaboration with NVIDIA advances infrastructure in parallel with accelerated computing and shortens the path to first token COLUMBUS, Ohio, Nov. 16, 2026 /PRNewswire/ -- Vertiv Holdings Co. (NYSE: VRT), a global leader in critical digital infrastructure, is proving the power, thermal management and controls infrastructure behind AI factories at the start of the engineering process, ahead of the silicon it supports, using the Vertiv ATLAS Lab, a system-level testing capability. ATLAS, short for Advanced Test Lab for Architecture and Systems, exists because five forces are intensifying across AI infrastructure at once: density, speed, scale, complexity and dynamic load profiles...
Alto Ingredients, Inc. to Participate in the Craig-Hallum 17th Annual Alpha Select Conference
PEKIN, Ill., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of renewable fuels, essential ingredients and specialty alcohols, today announced that management will take part in the Craig-Hallum 17th Annual Alpha Select Conference, conducting one-on-one meetings throughout the day on Tuesday, November 17, 2026...
StablecoinX Reports Third Quarter 2026 Results: Revenue Rises Nearly Eightfold Sequentially as DVN Surpasses $6 Billion in Cumulative Verified Volume
NEW YORK, Nov. 16, 2026 (GLOBE NEWSWIRE) -- StablecoinX Inc. (Nasdaq: USDE), the first public stablecoin infrastructure company focusing on the Ethena digital dollar ecosystem, today reported financial results for the third quarter ended September 30, 2026, its first full quarter as a public company. Third Quarter 2026 Highlights Revenue of $477,993 for the third quarter, a 666% increase from $62,372 in the second quarter of 2026, driven almost entirely by the Company's Decentralized Verifier Node (DVN) infrastructure services business, reflecting the first full quarter of DVN revenue-generating activity...
Nuo Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update
HOUSTON, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial-stage medical device company focused on developing and marketing regenerative therapies for chronic wound care, announced financial results for the third quarter ended September 30, 2026 and provided an operational and business update. Third Quarter and First Nine Months 2026 Financial Summary Total revenues of approximately $1.9 million and $4.9 million for the third quarter 2026 and first nine months of 2026, respectively, increased 80% and 123%, respectively, versus the comparable 2025 periods...
SCIENTURE Reports Q3 2026 Results with Approximately 265% Sequential Revenue Growth Driven by the Commercial Launch of REZENOPY™
Q3 2026 Revenue Increased Approximately 113% Year-Over-Year to $1.25 Million Arbli ™ generated approximately $330,000 and $730,000 of Net Product Revenue for Q3 2026 and the first nine months of 2026 respectively Initial Wholesale Shipments of REZENOPY ™ Generated Approximately $925,000 of Net Product Revenue Following Its August 2026 Launch Q3 2026 Gross Profit Increased Approximately 77.5% Year-Over-Year to $1.02 Million First Nine Months of 2026 Revenue Increased Approximately 176% Year-Over-Year to $1.65 Million and Gross Profit Increased Approximately 145% to $1.41 Million COMMACK, NY, Nov. 16, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture” or the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through the development, commercialization, and distribution of novel specialty products that address unmet market needs, today provided a business update and reported financial results for the three and nine months ended September 30, 2026...
Kaplan Fox Urges D-Wave Quantum Inc. (QBTS) Investors to Contact the Firm Before the Deadline on December 14, 2026
New York, New York--(Newsfile Corp. - November 16, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against D-Wave Quantum Inc. ("D-Wave" or the "Company") (NYSE: QBTS) on behalf of investors that purchased or otherwise acquired D-Wave securities between February 26, 2026 and August 25, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in D-Wave and have suffered losses, you may CLICK HERE to contact us...
Director Declaration
SHELL PLC DIRECTOR DECLARATION November 16, 2026 Pursuant to UKLR 6.4.9(2), Shell plc (the “Company”) announces that Dick Boer, Deputy Chair and Senior Independent Director of the Company, has been nominated for appointment as a member of the Supervisory Board of Koninklijke Philips N.V. (“Philips”)...
Sensors & Software and ProStar Announce Collaboration to Deliver PointMan as an Approved Preferred Precision Mapping Solution
GRAND JUNCTION, Colo., Nov. 16, 2026 (GLOBE NEWSWIRE) -- ProStar Holdings Inc. (“ProStar” or the “Company”) (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00) today announced a technical collaboration with Sensors & Software Inc., an international provider of ground penetrating radar (GPR) instrumentation and software and a subsidiary of SPX Technologies Inc. (NYSE: SPXC) approving PointMan as a preferred precision mapping solution for Sensors & Software's LMX200™ and LMX150™ GPR...
Lithium X2 Files Pre-Feasibility Study Technical Report for High-Grade Nevada North Lithium Project; Confirms Strong Economics
West Vancouver, British Columbia--(Newsfile Corp. - November 16, 2026) - Lithium X2 Mining Inc. (TSXV: LIXX) (OTCQX: LIXMF) (FSE: 9WI) (formerly Surge Battery Metals Inc.) (the "Company" or "Lithium X2") announces it has filed an independent National Instrument 43-101 ("NI 43-101") Technical Report for its 2026 Pre-Feasibility Study ("PFS") for the Nevada North Lithium Project ("NNLP") located in Elko County, north of Wells, Nevada. The Technical Report supports the PFS results announced on October 2, 2026 and contains no material differences from those results...
Mobilicom Announces Participation in Upcoming Industry & Investor Conferences
Company to Introduce SwarmiX to the UK Defense Market and Engage Institutional Investors at Upcoming Conferences Palo Alto, California, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB) (“Mobilicom” or the “Company”), a provider of cybersecure solutions for drones and robotics, today announced its participation in three upcoming industry and investor conferences in November and December 2026. The Company will introduce its recently launched SwarmiX solution to the UK defense market at the Loitering Munitions UK conference, following its debut at AUSA 2026 in the United States and subsequent presentation at UVID 2026 in Israel...
Canton Strategic Holdings, Inc. Releases Third Quarter 2026 Financial and Operational Results
Total revenue of $3 million, an increase of 104% since Q2, in the Company's first full quarter of Super Validator and locking-as-a-service operations NEW YORK, Nov. 16, 2026 /PRNewswire/ -- Canton Strategic Holdings, Inc. (Nasdaq: CNTN) ("Canton Strategic" or the "Company"), the first publicly traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial markets, today released financial and operating results for the third quarter ended September 30, 2026. During the quarter, the Company recorded total revenue of $3 million, compared with approximately $1.5 million in the second quarter of 2026, an increase of 104%...
HCW Biologics Reports Third Quarter 2026 Business and Clinical Development Highlights and Financial Results
MIRAMAR, Fla., Nov. 16, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on developing transformative fusion immunotherapeutics to treat autoimmune diseases, cancer and senescence-associated dysplasia, today reported financial results and recent business highlights for the three and nine months ended September 30, 2026...
Trulieve to Open Medical Cannabis Dispensary in Tampa, Florida
New Hillsborough County location will host grand opening celebration Friday, November 20 TALLAHASSEE, Fla., Nov. 16, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Tampa, Florida...
Brighthouse Financial Announces Preferred Stock Dividends and Related Depositary Share Distributions
CHARLOTTE, N.C.--(BUSINESS WIRE)--Brighthouse Financial, Inc. (“Brighthouse Financial” or the “company”) (Nasdaq: BHF) announced today that on December 28, 2026, holders of record as of December 10, 2026 (the “Record Date”) of (i) its depositary shares (the “Series A Depositary Shares” (Nasdaq: BHFAP)), each representing a 1/1,000th interest in a share of its 6.600% Non-Cumulative Preferred Stock, Series A (the “Series A Preferred Stock”), (ii) its depositary shares (the “Series B Depositary Sh...
Helium Evolution Launches Up to $3 Million Winter Seismic Program to Advance Exploration on 100% Working Interest Lands
Operated 2D seismic survey planned at Coderre, adjacent to recent Crown land sale activity
MNTN Shareholder Investigation - Contact Robbins LLP for Information About Your Rights
SAN DIEGO, Nov. 16, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP is investigating MNTN, Inc. (NYSE: MNTN) to determine whether certain MNTN officers and directors made false or misleading statements or failed to disclose material information regarding the Company's sales organization, employee retention, customer acquisition, and growth prospects. MNTN, Inc. operates a technology platform that brings performance marketing to Connected TV...
VEON Sets Out 2030 Growth and Shareholder Return Framework at Capital Markets Day
Targets 12–15% organic annual growth in USD revenue and EBITDA from 2026 to 2030 Targets annual shareholder returns of at least USD 200 million Aspires to reach 50% digital revenue mix
VivoSim Labs to Showcase Breakthrough Multiparametric NAMkind™ Liver and Intestine Data at the 2026 American College of Toxicology (ACT) Annual Meeting
New data on 10 compounds pulled due to unforeseen liver tox highlight how VivoSim's models often easily catch clinical failure risk missed by animal models, using a complex approach that leverages several parameters studied simultaneously New data on 10 compounds pulled due to unforeseen liver tox highlight how VivoSim's models often easily catch clinical failure risk missed by animal models, using a complex approach that leverages several parameters studied simultaneously
Superior Group of Companies Named to Forbes' 2027 America's Best Companies List
ST. PETERSBURG, Fla., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) today announced its inclusion on Forbes' 2027 America's Best Companies list.
Outdoor Holding Company Reports Second Quarter Fiscal 2027 Financial Results
Revenue increased 14.6% to $13.7 million and net income from continuing operations increased to $2.3 million; first-half cash flow from continuing operations improved by $16.4 million from the prior-year period
Kaplan Fox Reminds Webull Corporation (BULL) Investors to Seek a Leadership Role Before Deadline on December 7, 2026
New York, New York--(Newsfile Corp. - November 16, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Webull Corporation ("Webull" or the "Company") (NASDAQ: BULL) on behalf of investors that purchased or otherwise acquired Webull Class A ordinary shares between April 26, 2025 and October 6, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Webull and have suffered losses, you may CLICK HERE to contact us...
XORTX Completes Manufacturing of Clinical Drug Supply
● Clinical Drug Supply and Packaging completed in preparation for the XRX-OXY-102 Clinical Study ●
Apartments.com Launches 'Free Rent for a Year Sweepstakes'
One winner selected every week through the end of 2026 ARLINGTON, Va., Nov. 16, 2026 /PRNewswire/ -- Apartments.com, a CoStar Group (NASDAQ: CSGP) leading online real estate marketplace today announced that Apartments.com, the leading platform for apartment rentals, is launching its national "Free Rent for a Year Sweepstakes," giving eight renters the chance to start 2027 with one major expense off their plate: rent...
Erasca to Host Virtual Investor Event Highlighting Clinical Momentum Across Its RAS-Targeting Franchise
SAN DIEGO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it will host a virtual investor event on Friday, November 20, 2026, at 8:00 a.m. Eastern Time to discuss updated Phase 1 data for ERAS-0015, a potential best-in-class pan-RAS molecular glue for RAS-mutant solid tumors, and other updates...
Pearl Diver Credit Company Inc. Announces Third Quarter 2026 Financial Results
- Company to Host Conference Call and Webcast at 10:00 AM ET Today - NEW YORK and LONDON, Nov. 16, 2026 /PRNewswire/ -- Pearl Diver Credit Company Inc. (NYSE: PDCC, PDPA) (the "Company") today announced financial results for the third quarter ended September 30, 2026. "Last quarter we said we would monitor the environment closely and deploy selectively, and that is what we have done," said Indranil Basu, Chief Executive Officer of Pearl Diver Credit Company...
Nuvation Bio Presented Additional Long-Term Follow-Up Data from Phase 2 Study of Safusidenib in IDH1-Mutant Glioma at the 2026 Society for Neuro-Oncology Annual Meeting
With nearly 40 months of follow-up, additional updated data from J201 study show the confirmed clinical benefit rate was 81.5% in patients with Grade 2 IDH1-mutant glioma Patients achieved a median target lesion reduction of 27.2% Topline long-term follow-up results were previously announced in July 2026 NEW YORK, Nov. 16, 2026 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, announced new long-term follow-up data from the Phase 2 (J201) study of investigational safusidenib in patients with chemotherapy- and radiotherapy-naïve grade 2 IDH1-mutant glioma. The data, presented at the Society for Neuro-Oncology (SNO) 31st Annual Meeting in Philadelphia, demonstrated durable responses after longer follow-up, with a manageable safety profile...
Corbus Pharmaceuticals presents Phase 1b CANYON-1 clinical trial data for CRB-913 at ObesityWeek® 2026
CRB-913 demonstrated statistically significant and clinically meaningful mean weight loss of 5% at 60 mg after 12 weeks with no plateauing observed Corresponding significant reductions were also seen in waist circumference and body mass index (BMI) Treatment-emergent psychiatric adverse events (AEs) were infrequent, mostly mild, and in line with published GLP-1 data No serious or severe psychiatric AEs were reported, including no cases of severe or serious suicidality or depression Vomiting, nausea, and constipation occurred at lower rates and were milder than those reported in published studies of oral GLP-1s NORWOOD, Mass., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage company focused on developing new therapies in oncology and obesity, announced today that additional data from the CANYON-1 Phase 1b obesity study were presented in a poster at ObesityWeek 2026...
Virtuix Reports Second Quarter Fiscal 2027 Results, Including 105% Omni One Revenue Growth and 3.3X Order Increase
Total Quarterly Revenue Rises 55% Sequentially to $1.2 Million Following Meta Quest Launch Enterprise Orders Increase 45% as Virtuix Expands Robotics, Defense, and Healthcare Applications Company Enters into Non-Binding Letter of Intent to Acquire STS International as Part of Strategy to Expand Presence in Defense Market AUSTIN, Texas, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Virtuix Holdings Inc. (NASDAQ: VTIX) (the “Company”), a leading developer of full-body simulation systems, today reported financial and operational results for the second quarter of fiscal year 2027 ended September 30, 2026. Key Second Quarter Fiscal 2027 Results and Subsequent Highlights Revenue Growth: Omni One revenue increased 105% to $1.1 million, while total revenue increased 21% year-over-year and 55% sequentially to $1.2 million...
ADP to Present at Upcoming Investor Conference
ROSELAND, N.J., Nov. 16, 2026 /PRNewswire/ -- ADP (Nasdaq: ADP), a global leader in HR and payroll solutions, today announced that it will present at the Nasdaq Investor Conference in London on Tuesday, December 8, 2026 at 4:00 a.m.
Enphase Energy to Showcase Product Innovations at RE+ 2026
FREMONT, Calif., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company, today announced that it will showcase a range of current and new products for homes, businesses, and more at RE+ 2026 at the Las Vegas Convention Center from Nov. 17-19, 2026. Highlights include:
Cohen & Company Capital Markets Launches At-The-Market Offering Platform
Connor Leahey Joins to Lead the Firm's Expanding Capital Markets Business NEW YORK, Nov. 16, 2026 /PRNewswire/ -- Cohen & Company Capital Markets ("CCM"), a division of Cohen & Company Securities, LLC (Member FINRA, SIPC), an indirect controlled subsidiary of Cohen & Company Inc. (NYSE American: COHN) ("Cohen & Company" or the "Company"), today announced the launch of a dedicated At-the-Market ("ATM") offering practice, expanding the firm's equity capital markets capabilities by providing clients with another flexible capital formation solution. This new program will complement the firm's existing advisory and financing capabilities, which include IPO execution, private placements, PIPEs, and other equity-linked financings...
Silicon Motion to Attend Upcoming Investor Conferences
TAIPEI, Taiwan and MILPITAS, Calif., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (NasdaqGS: SIMO), a global leader in designing and marketing NAND flash controllers for solid state storage devices and automotive and boot drive solutions, today announced that it will participate in the following upcoming conferences: Morgan Stanley's 25th Annual Asia Pacific Summit Wednesday, November 18, 2026 (meetings only) Mandarin Oriental Singapore, SG Roth's 15th Annual Technology Conference Wednesday, November 18, 2026 (meetings only) Hard Rock Hotel New York, NY UBS Global Technology and AI Conference Monday, November 30, 11:35a.m...
Powerfleet Appoints Eddie Capel and John Strosahl to Board of Directors
Manhattan Associates Chairman and former CEO and former Jamf CEO bring extensive enterprise software, supply chain and SaaS leadership experience WOODCLIFF LAKE, N.J., Nov. 16, 2026 /PRNewswire/ -- Powerfleet, Inc. (Nasdaq: AIOT), a global leader in the artificial intelligence of things (AIoT) software-as-a-service (SaaS) mobile asset industry, today announced that Eddie Capel and John Strosahl have been appointed to its Board of Directors as independent directors, effective November 16, 2026...
performance-io and Semrush Study Links Top SEO Rankings to AI Visibility in Pharma
LONDON--(BUSINESS WIRE)--performance.io, the leading pharma and healthcare SEO/GEO agency, today announced early findings from a joint research study with Semrush, an Adobe company and leading brand visibility platform. The study examines how organic search rankings are closely associated with visibility in Google's AI Overviews across the pharmaceutical searches studied. When an AI Overview appeared, the domain holding the No. 1 organic position was cited 68.8% of the time. Yet pharma brand si...
GE HealthCare expands global collaborations to help define the future of photon-counting CT with Photonova™ Spectra
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an expansion of its global clinical and research collaborations to advance Photonova Spectra,i the company's next-generation photon-counting CT system. Following recent global regulatory clearances, leading academic hospitals and research institutions across North America, Europe and Asia are beginning structured evaluations of Photonova Spectra to further define its clinical utility, optimize imaging protocols and explore n...
Johnson & Johnson to acquire Ollin Biosciences and late-stage bispecific antibody with best-in-class potential in ophthalmology
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced it has entered into a definitive agreement to acquire Ollin Biosciences, Inc., (“Ollin”) a clinical-stage biopharmaceutical company developing therapies for serious eye diseases, for $2.2 billion upfront, with the potential for additional regulatory and commercial milestone payments. Johnson & Johnson will also enter into a separate development funding agreement with Blackstone Life Sciences (“Blackstone...
Estrella Immunopharma Highlights ARTEMIS® T-Cell Therapy Data Selected for ASH 2026, Demonstrating Deep and Durable Leukemia Responses and Superior Extramedullary Disease Clearance Versus Conventional CAR-T in Preclinical Models
EMERYVILLE, Calif.--(BUSINESS WIRE)--Estrella Immunopharma, Inc. (NASDAQ: ESLA) (“Estrella” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation ARTEMIS T-cell therapies for cancer and autoimmune diseases, today highlighted preclinical findings from an abstract accepted for poster presentation at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 12–15, 2026, in New Orleans, Louisiana. The research, described in...
PIVOT-006 Phase 3 Registrational Trial Demonstrates Unprecedented Improvement in Recurrence-Free Survival (RFS) for Intermediate-Risk and High-Grade Ta Non-Muscle Invasive Bladder Cancer (NMIBC)
– Cretostimogene reduced the risk of recurrence by 68%, demonstrating a statistically significant and clinically meaningful benefit with a hazard ratio of 0.32 (95% CI: 0.23, 0.45; p
ZJK Advances AI Server Hardware Program for Global Hyperscaler into Sample Qualification Stage
Dual-Shore Engineering Sample Deliveries Across China and Vietnam Hubs Position ZJK for Scalable Production in the Global AI Infrastructure Supply Chain
Bond Founder, CEO, and Long-Term Investors Agree to Eliminate Approximately $26.4 Million in Preferred Liquidation Preferences, Aligning Their Interests with Common Shareholders
Investors agree to convert approximately $13.2 million of Series B Preferred Stock into common shares at $2.03 per share, subject to a six-month lock-up Investors agree to convert approximately $13.2 million of Series B Preferred Stock into common shares at $2.03 per share, subject to a six-month lock-up
BioVie Presents New Biomarker Data Highlighting Biomarker-Defined Endotypes and Neuropeptide Y Response to Bezisterim at the 4th Long COVID International Conference 2026
New findings from the Phase 2 ADDRESS-LC trial identify two distinct biomarker-defined Long COVID endotypes 1 associated with different patient responses to bezisterim treatment.
Weatherford Awarded a Deepwater Managed Pressure Drilling Contract by Constellation for a Drillship Operation in Brazil
HOUSTON, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) today announced it has been awarded a contract by Constellation to provide deepwater managed pressure drilling (“MPD”) solutions for an exploration campaign in, one of the most closely watched global offshore markets. The award extends Weatherford's leadership in deepwater MPD and builds on the Company's position as the most widely deployed MPD provider in Brazil...
IN8bio Reports Updated Glioblastoma Data at SNO 2026 Demonstrating Median Overall Survival of 20.9 Months and 50% Two-Year Survival with Gamma-Delta T Cell Therapy
IN8bio Reports Updated Glioblastoma Data at SNO 2026 Demonstrating Median Overall Survival of 20.9 Months and 50% Two-Year Survival with Gamma-Delta T Cell
Akebia Enters into Term Loan Facility with Symbiotic Capital Worth Up to $140 Million
Initial $60 million tranche fully funded, proceeds of which were used to fully repay $55 million BlackRock loan facility
Neumora Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
IND application for NMRA-215 (NLRP3 inhibitor) submitted to the U.S. Food and Drug Administration
Jasper Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
REDWOOD CITY, Calif., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a clinical stage biotechnology company focused on the design and development of innovative therapies to treat immune-mediated diseases, today reported results for the fiscal quarter ended September 30, 2026, and provided a corporate update...
Adagio Medical Reports Third Quarter 2026 Results
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the third quarter ended September 30, 2026. Recent Business Highlights: Ultra-Low temperature ablation (“ULTA”) featured in four podium presentations at the VT Symposium 2026 held October 9-10 in New York, with topics spanning clinical experience, comp...
TCIM Comments on Glass Lewis Report Related to No Confidence Referendum at Voya Financial
NEW YORK--(BUSINESS WIRE)--TOMS Capital Investment Management (“TCIM”), which manages funds that together have an investment representing an approximately 4.65% economic interest in Voya Financial, Inc. (NYSE: VOYA) (“Voya” or the “Company”), today commented on a recommendation from proxy advisory firm Glass, Lewis & Co. (“Glass Lewis”) related to TCIM's non-binding resolution to allow shareholders to convey that they “no longer continue to have confidence in the board of directors (the “Bo...
Netlist to Showcase CXL® NVvault™ Memory Family at SC26 Targeting KV-Cache Management, In-Memory Databases and Virtual Machines
-Designs explore intelligent memory tiering, data persistence and DDR4 reuse- IRVINE, Calif., Nov. 16, 2026 /PRNewswire/ -- Netlist, Inc. (OTCQB: NLST), a leading innovator in advanced memory and storage solutions, today announced it will showcase three proof-of-concept (POC) designs from its CXL NVvault™ memory family at SC26, with an emphasis on AI infrastructure and key-value (KV) cache management...
Commerce Introduces Shopping Agent to Enable Conversational Shopping for BigCommerce Merchants
AUSTIN, Texas, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Commerce.com (Nasdaq: CMRC), the open commerce ecosystem built to help merchants win as AI reshapes how customers discover and buy, today introduced Shopping Agent for BigCommerce, now rolling out to eligible merchants ahead of the holiday selling season. Shopping Agent enables merchants to build and customize an AI-powered storefront assistant that reflects their brand and guides visitors as they browse and buy...
Eocene and Barcode Nanotech Report Progress in the Development of Tumor Microenvironment-Targeted Lipid Nanoparticles Formulation of Aramchol
A unique proprietary lipid nanoparticles (LNPs) novel formulation of Aramchol has been developed using FDA-approved Lipids The novel formulation is designed to redirect Aramchol's biodistribution to target tumor microenvironment (TME) in liver and GI tumors and selectively inhibit the activity of cells that drive fibrosis By selectively targeting TME cells that drive fibrosis, the Aramchol LNP treatment could make immunotherapy and other standard of care liver and GI cancer therapies, work better for more patients with minimal toxicity GIVATAYIM, Israel, Nov. 16, 2026 /PRNewswire/ -- Eocene Ltd. (NASDAQ: EOCN) ("Eocene" or the "Company") report today updates from its wholly owned subsidiary, Galmed Research & Development Ltd...
Nature's Sunshine Announces Partnership with Health and Fitness Expert Peter Nielsen
LEHI, Utah, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ: NATR), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, today announced a partnership with Peter Nielsen, a nationally recognized television personality and health and fitness coach. The collaboration combines Nielsen's wellness expertise and passion for digestive health with Nature's Sunshine's commitment to helping people live healthier, brighter lives...
MediWound to Host Virtual KOL Event on EscharEx® Phase III VALUE Study and Commercial Opportunity on December 2, 2026
MediWound to Host Virtual KOL Event on EscharEx Phase III VALUE Study and Commercial Opportunity on December 2, 2026 Leading wound care experts to discuss Phase II clinical evidence, the pivotal Phase III VALUE study, and the estimated $1.05 billion U.S. annual peak sales potential YAVNE, Israel, November 16, 2026 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it will host a virtual Key Opinion Leader (KOL) event on Wednesday, December 2, 2026, at 11:00 a.m...
Pixelworks Announces Board Authorization of Expanded Stock Repurchase Program
PORTLAND, Ore., Nov. 16, 2026 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW) ("Pixelworks" or the "Company"), a provider of innovative cinematic and enhanced visualization solutions, today announced that its Board of Directors has approved to increase Company's previously announced stock repurchase program by $5 million, bringing the total amount authorized under the program to $10 million of the Company's common stock...
Axcelis Announces Participation in Upcoming Investor Conference
BEVERLY, Mass., Nov. 16, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the UBS Global Technology and AI Conference taking place November 30 – December 3, 2026 at the Phoenician Hotel, Scottsdale, AZ...
FG Communities Holdings Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series A
CHARLOTTE, N.C., Nov. 16, 2026 (GLOBE NEWSWIRE) -- FG Communities Holdings Inc. (Nasdaq: FGC, FGCPP) (the “Company” or “FG Communities Holdings”) today announced that it has declared a quarterly cash dividend on its 8.00% Cumulative Preferred Stock, Series A (the “Preferred Stock”).
Trulieve Announces Preliminary Addition to the Russell 2000® and 3000® Indices
TALLAHASSEE, Fla., Nov. 16, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that the company is set to join to the Russell 2000 and 3000 Indices as part of the semi-annual Russell Indexes reconstitution, according to a preliminary list published by FTSE Russell on Friday, November 13, 2026...
NewGen Provides Business Update
BANGKOK, Nov. 16, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today provided an update on its businesses. Nodexus and NX One In July 2025, the Company acquired advanced cytometry intellectual property and equipment...
Nasus Pharma Appoints Nir Sassi as Chief Financial Officer
TEL AVIV, Israel, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE American: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced the appointment of Mr.
CHAR Tech Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of up to CDN$3.5 Million and Full Satisfaction of Bioveld Canada Loan
CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(OTC PINK:CTRNF)(FSE:68K), a leader in sustainable biomass energy solutions, today announced a non-brokered private placement of up to 3,500 convertible debenture units ("the Units") for gross proceeds of up to CDN$3,500,000 ("the Offering")...
Apnimed Reports Third Quarter 2026 Financial Results and Provides Corporate Update
New Drug Application (“NDA”) for AD109, with a proposed proprietary name Oxnimbi™ (aroxybutynin and atomoxetine) tablets, for oral use, remains under U.S. Food and Drug Administration (“FDA”) review with a February 28, 2027, Prescription Drug User Fee Act (“PDUFA”) goal date Commercial readiness activities advance in preparation for a potential U.S. launch Presented five abstracts at CHEST 2026, including two late-breakers, highlighting AD109 Phase 3 clinical data and the burden of OSA $351.8 million in cash and cash equivalents as of September 30, 2026, expected to fund the potential U.S. launch of Oxnimbi and operations into the second quarter of 2028 CAMBRIDGE, Mass., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed”), a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases, today announced its financial results for the third quarter ended September 30, 2026, and provided a corporate update...
ADM Announces More Than $60 Million in Investments at Decatur Oilseed Facility
DECATUR, Ill.--(BUSINESS WIRE)--ADM (NYSE: ADM), a global leader in innovative solutions from nature, today announced five projects totaling more than $60 million across its Decatur West oilseeds facility, continuing ADM's longstanding investment in its Decatur operations. The planned investments will support the Decatur West facility's operational reliability, safety, and efficiency by supporting projects including upgrading key processing units, enhancing plant-wide process control systems an...
Modern Mining Announces Conversion of Debentures, SAFE Agreements and Exercise of Warrants
GREENVILLE, N.C.--(BUSINESS WIRE)--Modern Mining Technology Corp. (“Modern Mining” or the “Company”) (NYSE American: MDRN), which recovers gold, silver, copper and other valuable metals from electronic waste using a proprietary aqueous-based process, today announced the conversion of its outstanding convertible debentures (the “Debentures”) into common shares (“Common Shares”) of the Company, conversion of the outstanding simple agreements for future equity (the “SAFEs”) and the automatic cashl...
Catheter Precision Partners With Two New German Heart Centers
VIVO Addresses Critical Need in Ventricular Ablations by Determining Targets with "GPS" Accuracy Initial Procedure Demonstrated Desired Outcomes with Successful Ablation and Termination of Multiple Irregular Rhythms FORT MILL, S.C., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE American: VJET), today announced the successful completion of a clinical evaluation and its first commercial case in Germany at Klinikum Bayreuth...
NeOnc CEO Amir Heshmatpour's 2026 Open-Market Share Purchases Exceed $1.5 Million
CALABASAS, Calif., Nov. 16, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) today announced that Amir F.
Cadre Holdings Announces Chief Financial Officer Transition
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Cadre Holdings, Inc. (NYSE: CDRE) (“Cadre” or “the Company”), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that Blaine Browers is stepping down as Chief Financial Officer, effective at year end, to pursue another opportunity as CFO of a diversified, large-cap manufacturer of engineered critical components. “On behalf...
Swarmer Completes Acquisition of Vataga Drone
AUSTIN, Texas--(BUSINESS WIRE)--Swarmer, Inc. (“Swarmer”) (Nasdaq: SWMR), a defense technology company whose autonomy software has supported more than 100,000 real-world combat missions in Ukraine since April 2024, today announced it has completed its previously announced acquisition of certain intellectual property of Vataga Drone (“Vataga”), a Ukrainian defense technology company specializing in first-person-view (“FPV”) and interceptor drones. The transaction, comprising cash and equity, pro...
Digimarc Announces Board Refreshment to Build on Strategic Transformation and Support Next Phase of Growth
BEAVERTON, Ore.--(BUSINESS WIRE)--Digimarc Corporation (NASDAQ: DMRC) (“Digimarc” or the “Company”), a leading provider of digital identity and authentication solutions, today announced the appointment of three new independent directors to its Board of Directors (the “Board”) as part of Digimarc's ongoing strategic transformation and to support the Company in its next phase of growth. The new directors are Andris (“Dris”) Upitis, Founder and Chief Investment Officer of Ocho Investments LLC (“Oc...
FORT Robotics Reports Strong 2026 Momentum as Company Progresses Towards a Public Listing in Partnership with Newbury Street II Acquisition Corp
PHILADELPHIA and BOSTON, Nov. 16, 2026 (GLOBE NEWSWIRE) -- FORT Robotics, the Trust Layer for Physical AI, and Newbury Street II Acquisition Corp (Nasdaq: NTWO), a special purpose acquisition company, today announced the public filing of a registration statement on Form S-4 with the U.S. Securities and Exchange Commission, which can be viewed on FORT's investor relations website at www.fortrobotics.com/investors and on the SEC's website at www.sec.gov . The filing is a key step towards completing their previously announced proposed business combination under which FORT will become a publicly traded company...
Iambic Provides Business Updates and Third Quarter 2026 Financial Results
Launched Enchant v3, a 41-billion-parameter transformer model for drug discovery and development, to drive decisions across our internal and partnership activities Signed AI discovery collaborations with Bayer and AbbVie; eight total partnerships signed since 2024 Achieved a program milestone in Takeda collaboration, triggering a $1.0 million payment; AI-driven drug discovery collaboration was announced only nine months ago in February 2026 Presented updated IAM1363 (HER2) data from ongoing Phase 1/2 study at ESMO 2026: 36% systemic and 41% intracranial best overall response rates in heavily pretreated patients; registrational trial planned for 2027, subject to regulatory approval Submitted IND and received a Safe-to-Proceed Letter from the FDA for the IAM217 (KIF18A) Phase 1/2 trial; IND submission for IAM-C1 (CDK2/4) is on track for Q4 2026 Meaningful revenue generation: YTD (through Q3 2026), collaboration revenue was approximately $24 million, where billings from collaborations were approximately $100 million; for the same period, Iambic's total operating expenses were approximately $108 million and costs related to compute were less than $10 million Strong cash position: As of September 30, 2026, the cash and cash equivalents position was approximately $252 million, where the pro-forma cash and cash equivalents position was approximately $455 million and includes net proceeds of approximately $156 million from our IPO and AbbVie upfront payments received in October 2026 SAN DIEGO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Iambic (Nasdaq: IAM), a clinical-stage life sciences and technology company developing novel medicines using its AI-driven platform, today provided business updates and financial results for the third quarter ended September 30, 2026. “Iambic's mission is to make better technology for better medicines, and we believe that the past several months showed that at work across every part of our business,” said Tom Miller, PhD, Co-Founder & CEO of Iambic...
ALX Oncology Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Expect to report safety and early efficacy data from the Phase 1 dose-escalation study of ALX2004 in EGFR-expressing solid tumors and plan to host a KOL webinar to review the results in December 2026 Topline data from 120 patients in Phase 2 ASPEN-09-Breast clinical trial evaluating evorpacept in combination with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer expected in 2H 2027 SOUTH SAN FRANCISCO, Calif., Nov. 16, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology," Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today reported financial results for the third quarter ended September 30, 2026, and provided a corporate update...
Corvex Signs $103 Million Take-or-Pay Agreement for NVIDIA Blackwell Capacity; $21 Million of Annual Contract Revenue per Megawatt
3-Year Agreement Will More Than Double Mid-Atlantic 1 Contracted Annual Recurring Revenue from $22 Million to Approximately $56 Million Customer Prepayment and Debt Financing Fund More Than 80% of Deployment Corvex Diversifies Its Customer Base With Another Scaled Inference Platform Customer Deployment Expected to Be Fully in Service in the First Quarter of 2027 ARLINGTON, Va., Nov. 16, 2026 /PRNewswire/ -- Corvex, Inc. (Nasdaq: MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, today announced a three-year, $103 million take-or-pay agreement to provide NVIDIA Blackwell computing capacity to a scaled AI inference platform...
Humacyte Presents Long-Term Clinical Data Demonstrating Low Atherosclerosis Susceptibility in Acellular Tissue Engineered Vessel
– Analysis of ATEVs from 52 patients across five clinical trials, some implanted for more than five years, found minimal lipid buildup and no evidence of vulnerable plaques. – First long-term clinical evaluation of atherosclerosis susceptibility in a tissue engineered vessel.
Enlivex Announces Pricing of $7.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Nes-Ziona, Israel, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced that it has entered into a securities purchase agreement with certain investors for the purchase and sale, in a registered direct offering, of an aggregate of $7,500,000 of the Company's ordinary shares (or pre-funded warrants in lieu thereof), together with accompanying ordinary warrants to purchase up to an equal number of ordinary shares, at a combined purchase price of $1.315 per ordinary share (or $1.314 per pre-funded warrant) and accompanying ordinary warrant, representing a premium of 10.5% to the Nasdaq official closing price of the ordinary shares on November 13, 2026 (the “Registered Offering”)...
Lichen International Limited Accelerates Strategic Transformation and Adopts Dual-Driven Model to Enable High-Quality Growth
XIAMEN, China, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Lichen International Limited (Nasdaq: LICN) (“Lichen International” or the “Company”), a dedicated financial and taxation service provider in China, today announced it has accelerated its strategic transformation and adopted a dual-driven model to enable high-quality growth. China's financial consulting industry is facing intense competition...
Galectin Therapeutics Reports September 30, 2026 Financial Results and Provides Business Update
NORCROSS, Ga., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three months ended September 30, 2026.
ESMO Rare Cancers Publishes Case Report Detailing Eight-Year Response to Relacorilant Plus Nab-Paclitaxel in Metastatic Vulvar Cancer
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced publication of a peer-reviewed case report in ESMO Rare Cancers, regarding an approximately eight-year response to relacorilant plus nab-paclitaxel in a patient with metastatic vulva...